301230 泓博醫藥
按盤價 
25.150 +3.140 (+14.266%)
25.150 +3.140 (+14.266%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.465 | 3.373 | 9.194 | 24.060 | 21.022 |
| 總資產報酬率 ROA (%) | 1.102 | 2.698 | 7.227 | 16.206 | 15.254 |
| 投入資產回報率 ROIC (%) | 1.222 | 2.925 | 7.847 | 18.619 | 17.656 | 邊際利潤分析 |
| 銷售毛利率 (%) | 23.779 | 30.875 | 36.874 | 38.688 | 42.566 |
| 營業利潤率 (%) | 3.950 | 7.646 | 15.211 | 19.336 | 19.538 |
| 息稅前利潤/營業總收入 (%) | 4.019 | 7.388 | 13.687 | 20.267 | 23.127 |
| 淨利潤/營業總收入 (%) | 6.012 | 7.682 | 14.028 | 16.416 | 17.206 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 8.592 | 107.784 | 95.280 | 100.765 | 94.235 |
| 價值變動淨收益/利潤總額(%) | 52.148 | 16.890 | 0.691 | 2.551 | 3.017 |
| 營業外收支淨額/利潤總額(%) | 0.674 | -1.854 | 0.105 | -0.501 | -0.138 | 償債能力分析 |
| 流動比率 (X) | 3.691 | 3.824 | 9.284 | 2.154 | 2.782 |
| 速動比率 (X) | 3.291 | 3.503 | 8.778 | 1.791 | 2.052 |
| 資產負債率 (%) | 24.676 | 24.854 | 14.476 | 37.534 | 24.847 |
| 帶息債務/全部投入資本 (%) | 3.445 | 3.369 | 2.505 | 10.776 | 13.777 |
| 股東權益/帶息債務 (%) | 2,423.409 | 2,473.390 | 3,608.381 | 672.302 | 617.490 |
| 股東權益/負債合計 (%) | 305.251 | 302.350 | 590.777 | 166.427 | 302.468 |
| 利息保障倍數 (X) | 95.498 | -61.885 | -8.885 | 19.715 | 6.397 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 66.660 | 61.593 | 64.138 | 52.308 | 62.091 |
| 存貨周轉天數 (天) | 59.564 | 59.822 | 58.265 | 70.563 | 107.857 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
